Health Catalyst (HCAT) Revenue & Revenue Breakdown
Health Catalyst Revenue Highlights
Latest Revenue (Y)
$306.58M
Latest Revenue (Q)
$79.41M
Main Segment (Y)
Recurring Technology
Health Catalyst Revenue by Period
Health Catalyst Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $306.58M | 3.60% |
| 2023-12-31 | $295.94M | 7.13% |
| 2022-12-31 | $276.24M | 14.18% |
| 2021-12-31 | $241.93M | 28.11% |
| 2020-12-31 | $188.84M | 21.88% |
| 2019-12-31 | $154.94M | 37.63% |
| 2018-12-31 | $112.57M | 54.04% |
| 2017-12-31 | $73.08M | - |
Health Catalyst generated $306.58M in revenue during NA 2024, up 3.60% compared to the previous quarter, and up 197.87% compared to the same period a year ago.
Health Catalyst Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $79.41M | -0.24% |
| 2024-12-31 | $79.61M | 4.26% |
| 2024-09-30 | $76.35M | 0.59% |
| 2024-06-30 | $75.90M | 1.58% |
| 2024-03-31 | $74.72M | -0.48% |
| 2023-12-31 | $75.08M | 1.78% |
| 2023-09-30 | $73.77M | 0.76% |
| 2023-06-30 | $73.21M | -0.89% |
| 2023-03-31 | $73.87M | 6.80% |
| 2022-12-31 | $69.16M | 1.18% |
| 2022-09-30 | $68.35M | -3.23% |
| 2022-06-30 | $70.63M | 3.74% |
| 2022-03-31 | $68.09M | 5.21% |
| 2021-12-31 | $64.72M | 4.83% |
| 2021-09-30 | $61.74M | 3.54% |
| 2021-06-30 | $59.63M | 6.77% |
| 2021-03-31 | $55.85M | 4.82% |
| 2020-12-31 | $53.28M | 12.90% |
| 2020-09-30 | $47.19M | 9.09% |
| 2020-06-30 | $43.26M | -4.12% |
| 2020-03-31 | $45.12M | 3.71% |
| 2019-12-31 | $43.50M | 10.34% |
| 2019-09-30 | $39.42M | 7.12% |
| 2019-06-30 | $36.80M | 4.52% |
| 2019-03-31 | $35.21M | -2.41% |
| 2018-12-31 | $36.08M | 9.78% |
| 2018-09-30 | $32.87M | 42.97% |
| 2018-06-30 | $22.99M | 11.43% |
| 2018-03-31 | $20.63M | - |
Health Catalyst generated $79.41M in revenue during Q1 2025, up -0.24% compared to the previous quarter, and up 105.77% compared to the same period a year ago.
Health Catalyst Revenue Breakdown
Health Catalyst Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Recurring Technology | $194.85M | $187.23M | $175.81M | $147.45M | $110.47M |
| One-time Technology | - | $357.00K | $480.00K | $272.00K | - |
Latest
Health Catalyst's latest annual revenue breakdown by segment (product or service), as of Dec 24: Recurring Technology (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurring Technology | $52.88M | $51.48M | $99.23M | $48.65M | $46.97M | $47.00M | $45.97M | $47.32M | $46.93M | $44.66M | $44.00M | $45.40M | $41.75M | $40.09M | $38.26M | $35.53M | $33.57M | $32.32M | $27.96M | $25.49M |
| One-Time Technology | - | - | - | - | - | - | - | $258.00K | - | - | $480.00K | - | - | $272.00K | - | - | - | - | - | - |
Latest
Health Catalyst's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Recurring Technology (100.00%).
Health Catalyst Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ATLN | Atlantic | $442.61M | $129.55M |
| HCAT | Health Catalyst | $306.58M | $79.41M |
| STIM | Neuronetics | $74.89M | $38.11M |
| CDXS | Codexis | $59.34M | $7.54M |
| SGMO | Sangamo Therapeutics | $57.80M | $6.44M |
| OABI | OmniAb | $26.39M | $4.15M |
| IVVD | Invivyd | $25.38M | $11.30M |
| ACRS | Aclaris Therapeutics | $18.72M | $1.46M |
| PYXS | Pyxis Oncology | $16.15M | - |
| OBIO | Orchestra BioMed | $2.64M | $836.00K |
| SAVA | Cassava Sciences | - | - |